We are live on ! Find out more
Man Group

Man Group Portfolio holdings

AUM $55.1B
1-Year Est. Return 24.23%
This Fund
S&P 500
This Quarter Est. Return
+9.86%
1 Year Est. Return
+24.23%
3 Year Est. Return
+82.67%
5 Year Est. Return
+105.49%
10 Year Est. Return
AUM
$27.9B
AUM Growth
+$6.35B
Cap. Flow
+$3.76B
Cap. Flow %
13.48%
Top 10 Hldgs %
12.67%
Holding
2,368
New
371
Increased
836
Reduced
637
Closed
381

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$228M
2
KO icon
Coca-Cola
KO
+$167M
3
AAPL icon
Apple
AAPL
+$131M
4
MDLZ icon
Mondelez International
MDLZ
+$121M
5
UNH icon
UnitedHealth
UNH
+$116M

Sector Composition

Rank Sector Weight
1 Technology 19.75%
2 Healthcare 15.02%
3 Consumer Discretionary 12.4%
4 Financials 11.54%
5 Industrials 11.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIVI icon
1726
BioVie
BIVI
$10.3M
$143K ﹤0.01%
+183
New +$98.9K
AEO icon
1727
American Eagle Outfitters
AEO
$2.85B
$142K ﹤0.01%
10,183
-4,415
-30% -$56.6K
RCEL icon
1728
Avita Medical
RCEL
$142M
$142K ﹤0.01%
+21,513
New +$129K
OOMA icon
1729
Ooma
OOMA
$550M
$142K ﹤0.01%
+10,400
New +$154K
PUMP icon
1730
ProPetro Holding
PUMP
$1.45B
$141K ﹤0.01%
13,560
-16,189
-54% -$170K
VKTX icon
1731
Viking Therapeutics
VKTX
$4.04B
$141K ﹤0.01%
14,953
-167,730
-92% -$749K
TERN
1732
DELISTED
Terns Pharmaceuticals
TERN
$140K ﹤0.01%
+13,763
New +$91.6K
BDN
1733
Brandywine Realty Trust
BDN
$551M
$140K ﹤0.01%
+22,754
New +$146K
ARAY icon
1734
Accuray
ARAY
$28.4M
$139K ﹤0.01%
+66,551
New +$137K
ALDX icon
1735
Aldeyra Therapeutics
ALDX
$91.7M
$139K ﹤0.01%
+19,967
New +$114K
YMAB
1736
DELISTED
Y-mAbs Therapeutics
YMAB
$138K ﹤0.01%
28,343
+18,043
+175% +$131K
PHLT
1737
DELISTED
Performant Healthcare Inc
PHLT
$138K ﹤0.01%
+38,166
New +$89.4K
ATNM icon
1738
Actinium Pharmaceuticals
ATNM
$27M
$137K ﹤0.01%
+12,901
New +$131K
INSG icon
1739
Inseego
INSG
$108M
$136K ﹤0.01%
16,190
CVGI icon
1740
Commercial Vehicle Group
CVGI
$157M
$135K ﹤0.01%
+19,786
New +$115K
SPRY icon
1741
ARS Pharmaceuticals
SPRY
$590M
$134K ﹤0.01%
+15,670
New +$102K
XAIR icon
1742
Beyond Air
XAIR
$3.72M
$134K ﹤0.01%
+51
New +$130K
TUSK icon
1743
Mammoth Energy Services
TUSK
$132M
$133K ﹤0.01%
+15,365
New +$87.5K
GRTS
1744
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$133K ﹤0.01%
+38,472
New +$110K
RRGB icon
1745
Red Robin
RRGB
$134M
$131K ﹤0.01%
23,500
+12,200
+108% +$90.8K
CODX
1746
Co-Diagnostics
CODX
$7.74M
$131K ﹤0.01%
1,731
+30
+2% +$2.81K
FENC icon
1747
Fennec Pharmaceuticals
FENC
$347M
$131K ﹤0.01%
+13,630
New +$121K
RAIN
1748
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$130K ﹤0.01%
+16,259
New +$102K
VMD icon
1749
Viemed Healthcare
VMD
$451M
$129K ﹤0.01%
+17,127
New +$116K
GTHX
1750
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$129K ﹤0.01%
+23,760
New +$199K

Similar funds

Man Group's Q4 2022 Portfolio in Review

As of Q4 2022, Man Group held 2,368 positions worth $27.9B, up 29% from $21.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Man Group deployed $3.76B of net new capital in Q4 2022, opening 371 new positions and adding to 836 existing holdings. Its largest new stake was Textron: 910,556 shares worth $64.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Public Storage, an estimated $80.2M trimmed.

  • Man Group's largest Q4 2022 buy was Textron: 910,556 shares worth $64.5M.
  • Man Group added most to PepsiCo in Q4 2022, an estimated $228M increase.
  • Man Group's biggest Q4 2022 reduction was Public Storage, cutting an estimated $80.2M.
  • Man Group fully exited ZENDESK INC in Q4 2022, selling an estimated $69.1M.
  • Man Group's ten largest holdings make up 13% of its $27.9B portfolio in Q4 2022.
  • Man Group opened 371 new positions and closed 381 in Q4 2022.
  • Man Group's portfolio value rose 29% quarter-over-quarter to $27.9B.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.